Biopharmaceuticals Manufacturing Consumables Testing Market Analysis 2034
Global Biopharmaceuticals Manufacturing Consumables Testing Market Growth, Size, Trends Analysis - By Service, By Raw Material - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: HLCA25320 | Pages: 1 - 273 | Formats*: |
| Category : Healthcare | |||
Global Biopharmaceuticals Manufacturing Consumables Testing Market Introduction and Overview
According to SPER Market Research, the Global Biopharmaceuticals Manufacturing Consumables Testing Market is estimated to reach USD 2098.43 million by 2034 with a CAGR of 12.62%.
The report includes an in-depth analysis of the Global Biopharmaceuticals Manufacturing Consumables Testing Market, including market size and trends, product mix, Applications, and supplier analysis. The global market for testing biopharmaceutical manufacturing consumables was valued at USD 639.35 million in 2024 and is anticipated to experience a compound annual growth rate (CAGR) of 12.62% from 2025 to 2034. The ongoing enhancement of manufacturing capabilities within the biopharmaceutical sector is fueling the demand for consumables and testing services that are essential for maintaining product quality and adhering to regulatory standards. As new production lines are introduced and existing ones are expanded, the Biopharmaceuticals Manufacturing Consumables Testing Market is set for significant growth.
By Service Insights
The compendial and multicompendial laboratory testing segment led the market in 2024, holding the largest share due to many providers meeting various compendial standards. The need for full-monograph testing by region-specific pharmacopeias has made this segment costly, increasing its revenue. Meanwhile, the custom testing segment is projected to grow the fastest, driven by the demand for tailored testing protocols amid the rise of specialized biopharmaceuticals. This trend is further supported by personalized medicine and the need for specific analyses of excipients, which will enhance growth in this area.
By Raw Material Insights
The segment of active pharmaceutical ingredients (API) led the global market for biopharmaceutical manufacturing consumables testing, achieving the largest revenue share in 2024. APIs are frequently combined with excipients, which are also referred to as additives, to improve the absorption, stability, and solubility of medications. The incorporation of APIs offers therapeutic benefits; drug formulations consist of various components, including coatings, to facilitate delivery, enhance patient adherence, and ensure stability.
Regional Insights
North America led the biopharmaceuticals manufacturing consumables testing market, capturing the largest share of revenue in 2024, primarily due to the high concentration of biopharmaceutical manufacturing facilities in the region. Additionally, the continuous advancements in the research and development sector are propelling the demand for consumables testing, establishing the region as a global center for the biopharmaceutical manufacturing industry. Moreover, strategic acquisitions and investments in analytical equipment are enhancing testing capabilities and reinforcing market leadership.
Market Competitive Landscape
Prominent companies in the biopharmaceuticals manufacturing consumables testing market include Alcami Corporation, Merck KGaA, Catalent, Inc, Charles River Laboratories, among others. These service providers have established strategic alliances with various renowned biopharmaceutical firms globally. The companies are focused on meeting evolving regulatory requirements and addressing the growing demand. Agilent Technologies, Inc. operates within the life sciences and diagnostics sector, offering solutions for biopharmaceuticals manufacturing consumables testing. The company produces and supplies a range of analytical instruments and consumables, such as HPLC columns, standards, and reference materials.
Recent Developments:
In June 2024, MilliporeSigma inaugurated a cutting-edge quality control facility at its Darmstadt location, enhancing its analytical and microbial testing capabilities, supported by GMP-compliant laboratories and sustainable infrastructure to meet global demand.
In September 2024, Pace Life Sciences expanded its service offerings by acquiring Catalent's analytical services laboratory located in Research Triangle Park, North Carolina. This acquisition fortifies Pace's network, incorporating expertise in small molecule biopharmaceutical manufacturing consumables testing and analytical services to assist pharmaceutical clients from the early stages of development through to commercialization.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Service, By Raw Material |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Alcami Corporation, Merck KGaA, Eurofins Scientific, Agilent Technologies, Inc, Charles River Laboratories, Catalent, Inc, Element Materials Technology (Avomeen Analytical Services), Pace Analytical Services, LLC, Nelson Laboratories, LLC. |
Key Topics Covered in the Report
- Global Biopharmaceuticals Manufacturing Consumables Testing Market Size (FY’2021-FY’2034)
- Overview of Global Biopharmaceuticals Manufacturing Consumables Testing Market
- Segmentation of Global Biopharmaceuticals Manufacturing Consumables Testing Market By Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial & Multi Compendial Laboratory Testing)
- Segmentation of Global Biopharmaceuticals Manufacturing Consumables Testing Market By Raw Material (Formulation Excipients, Active Pharmaceutical Ingredients)
- Statistical Snap of Global Biopharmaceuticals Manufacturing Consumables Testing Market
- Expansion Analysis of Global Biopharmaceuticals Manufacturing Consumables Testing Market
- Problems and Obstacles in Global Biopharmaceuticals Manufacturing Consumables Testing Market
- Competitive Landscape in the Global Biopharmaceuticals Manufacturing Consumables Testing Market
- Details on Current Investment in Global Biopharmaceuticals Manufacturing Consumables Testing Market
- Competitive Analysis of Global Biopharmaceuticals Manufacturing Consumables Testing Market
- Prominent Players in the Global Biopharmaceuticals Manufacturing Consumables Testing Market
- SWOT Analysis of Global Biopharmaceuticals Manufacturing Consumables Testing Market
- Global Biopharmaceuticals Manufacturing Consumables Testing Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Biopharmaceuticals Manufacturing Consumables Testing Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Biopharmaceuticals Manufacturing Consumables Testing Market
7.Global Biopharmaceuticals Manufacturing Consumables Testing Market, By Service (USD Million) 2021-2034
7.1.Laboratory Testing7.2.Custom Testing / Customer Proprietary Testing7.3.Compendial & Multi Compendial Laboratory Testing
8.Global Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material (USD Million) 2021-2034
8.1.Formulation Excipients8.2.Active Pharmaceutical Ingredients (API)
9.Global Biopharmaceuticals Manufacturing Consumables Testing Market, (USD Million) 2021-2034
9.1.Global Biopharmaceuticals Manufacturing Consumables Testing Market Size and Market Share
10.Global Biopharmaceuticals Manufacturing Consumables Testing Market, By Region, (USD Million) 2021-2034
10.1.Asia-Pacific
10.1.1.Australia10.1.2.China10.1.3.India10.1.4.Japan10.1.5.South Korea10.1.6.Rest of Asia-Pacific
10.2.Europe
10.2.1.France10.2.2.Germany10.2.3.Italy10.2.4.Spain10.2.5.United Kingdom10.2.6.Rest of Europe
10.3.Middle East and Africa
10.3.1.Kingdom of Saudi Arabia10.3.2.United Arab Emirates10.3.3.Qatar10.3.4.South Africa10.3.5.Egypt10.3.6.Morocco10.3.7.Nigeria10.3.8.Rest of Middle-East and Africa
10.4.North America
10.4.1.Canada10.4.2.Mexico10.4.3.United States
10.5.Latin America
10.5.1.Argentina10.5.2.Brazil10.5.3.Rest of Latin America
11.Company Profile
11.1.Alcami Corporation
11.1.1.Company details11.1.2.Financial outlook11.1.3.Product summary11.1.4.Recent developments
11.2.Merck KGaA
11.2.1.Company details11.2.2.Financial outlook11.2.3.Product summary11.2.4.Recent developments
11.3.Eurofins Scientific
11.3.1.Company details11.3.2.Financial outlook11.3.3.Product summary11.3.4.Recent developments
11.4.Agilent Technologies, Inc
11.4.1.Company details11.4.2.Financial outlook11.4.3.Product summary11.4.4.Recent developments
11.5.Charles River Laboratories
11.5.1.Company details11.5.2.Financial outlook11.5.3.Product summary11.5.4.Recent developments
11.6.Catalent, Inc
11.6.1.Company details11.6.2.Financial outlook11.6.3.Product summary11.6.4.Recent developments
11.7.Element Materials Technology (Avomeen Analytical Services)
11.7.1.Company details11.7.2.Financial outlook11.7.3.Product summary11.7.4.Recent developments
11.8.Pace Analytical Services, LLC
11.8.1.Company details11.8.2.Financial outlook11.8.3.Product summary11.8.4.Recent developments
11.9.Nelson Laboratories, LLC
11.9.1.Company details11.9.2.Financial outlook11.9.3.Product summary11.9.4.Recent developments
11.10.Others
12.Conclusion
13.List of Abbreviations
14.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Biopharmaceuticals Manufacturing Consumables Testing Market CAGR of 12.62% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Biopharmaceuticals Manufacturing Consumables Testing Market size is USD 2098.43 million from 2025 to 2034.
Biopharmaceuticals Manufacturing Consumables Testing Market covered By Service, By Raw Material
The North America is anticipated to have the highest Market share in the Biopharmaceuticals Manufacturing Consumables Testing Market.
Alcami Corporation, Merck KGaA, Eurofins Scientific, Agilent Technologies, Inc, Charles River Laboratories, Catalent, Inc, Element Materials Technology (Avomeen Analytical Services), Pace Analytical Services, LLC, Nelson Laboratories, LLC.
The report includes an in-depth analysis of the Global Biopharmaceuticals Manufacturing Consumables Testing Market, including market size and trends, product mix, Applications, and supplier analysis.
Biopharmaceuticals Manufacturing Consumables Testing Market is projected to reach USD 2098.43 million by 2034, growing at a CAGR of 12.62% during the forecast period.
Biopharmaceuticals Manufacturing Consumables Testing Market size from 2025. The Market is expected to reach USD 2098.43 million by 2034, at a CAGR of 12.62% during the forecast period.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
